[Agranulocytosis caused by foreign analgesics (Optalidon and Nolotil)].
D000284:Administration, Oral; D000380:Agranulocytosis / Q000139:chemically induced*; D000632:Aminopyrine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001463:Barbiturates / Q000009:adverse effects; D002086:Butylscopolammonium Bromide / Q000009:adverse effects; D002110:Caffeine; D004177:Dipyrone / Q000009:adverse effects*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008875:Middle Aged; D004366:Nonprescription Drugs; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D013030:Spain
D000700:Analgesics; D001463:Barbiturates; D004338:Drug Combinations; D004366:Nonprescription Drugs; D011720:Pyrazoles; D000632:Aminopyrine; D002086:Butylscopolammonium Bromide; D002110:Caffeine; C020440:optalidon; D004177:Dipyrone
Agranulocytose etter bruk av utenlandske "hodepinetabletter" (Optalidon og Nolotil).